In contrast, when we analysed the tumours of the mice, we found high levels of the miR-155 targets SOCS1 and C/EBPβ and low pY-STAT3 levels in anti-miR-155-treated tumours, suggesting long-term target regulation. The gene discussed is STAT3; the disease is neoplasm.